@FierceMedDev: Malaysia is working hard to diversify its med device manufacturing base. International competition is increasing. News | Follow @FierceMedDev
@MarkHFierce: Barron's sees J&J poised for major growth, but NOT through its med device business. More | Follow @MarkHFierce
@DamianFierce: Quintiles is handling recruitment and "clinical services" for AstraZeneca's novel depression drug. Story | Follow @DamianFierce
> Despite regulatory concerns and the ire of Warren Buffett, Johnson & Johnson ($JNJ) may still be poised for growth, Barron's writes. Article
> ConvaTec has made the leap to India, opening a headquarters in Bangalore, looking to cash in on the country's fast-growing market for medical devices and equipment. More
> Abbott Laboratories ($ABT) got FDA clearance for a new testosterone diagnostic assay the company says can measure the hormone at low levels, helping guide treatment. Release
> Qiagen gained approval from China's State Food and Drug Administration for its careHPV test and instrument platform. Item
> VC outfit Apple Tree Partners has struck a $305 million licensing deal designed to raise funds to build up a collection of biotech and medical device companies. News
> Andrew Technologies snagged 510(k) clearance for its HydraSolve lipoplasty system. Item
> Dominion Diagnostics inked an exclusive deal with LifeGen for licensing rights to patented genetic testing. Release
> MC10, a Cambridge, MA, developer of stretchable electronics raised $10 million in a Series C, led by Medtronic ($MDT). Story
Biotech News
@FierceBiotech: Baxter joins Big Pharma funds on $38M B round for Naurex anti-depression R&D. Article | Follow @FierceBiotech
@JohnCFierce: Troubled Intercell (bought Iomai) throws in the towel, signs off on merger deal with Vivalis. More | Follow @JohnCFierce
@RyanMFierce: Dang. Another biotech deal this busy am. Naurex nails down $38M B round led by Baxter for depression candidate. Release | Follow @RyanMFierce
> Tranzyme takes a beating after scuttling another drug study. Report
> Apple Tree inks $305M drug deal to back biotech portfolio game plan. News
> Phenex grabs $135M discovery deal with J&J. Item
Pharma News
@FiercePharma: AstraZeneca beats back would-be Crestor copycats. Report | Follow @FiercePharma
> France herds patients, pharmacists toward cheap generics. News
> Teva taps S. Korea's Handok for assault on $14B market. Story
> U.S. branded sales to end 2012 with 3.5% decline. Article
Biotech IT News
> How lessons from iPhone's Siri aid biological exploration. Story
> GlaxoSmithKline dials up Vodafone for mobile tech alliance. Article
> Russian billionaire backs 23andMe in $50M round. News
> Could computers predict the next big Alzheimer's drug? Report
CRO News
> Patheon closes $255M Banner deal. Item
> Charles River projects a modest 2013, slides on the Street. Story
> Catalent inks biosimilar deal with Japanese CMO. Article
> Quintiles recruiting for AstraZeneca's novel depression drug. News
> Warnex closes bioanalytics sale, exits CRO biz. Report